MWA
AVNS icon

Monograph Wealth Advisors’s Avanos Medical AVNS Stock Holding History

Monograph Wealth Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,289
Closed -$329K – 145
2025
Q4 		$329K Hold
29,289
– – 0.03% 109
2025
Q3 		$339K Buy
+29,289
New +$343K 0.03% 113
2024
Q4 		– Sell
-9,902
Closed -$238K – 115
2024
Q3 		$238K Buy
+9,902
New +$226K 0.03% 101

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Monograph Wealth Advisors's AVNS Position: Q1 2026 in Review

Monograph Wealth Advisors sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 29,289 shares — an estimated $329K sold.

Monograph Wealth Advisors first reported a position in AVNS in Q3 2024 and held it in 3 quarters. The position peaked at $339K in Q3 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Monograph Wealth Advisors reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Monograph Wealth Advisors sold 29,289 Avanos Medical shares in Q1 2026, an estimated $329K.
  • Monograph Wealth Advisors first reported a position in Avanos Medical in Q3 2024 and held it in 3 quarters.
  • Monograph Wealth Advisors's Avanos Medical position peaked at $339K in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Monograph Wealth Advisors's 13F filing for Q1 2026, filed 13 May 2026.